Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research focused on Lung cancer and Cancer, with related work in Stage (stratigraphy), China, Thoracoscopy. Notable publications include 'Cancer situation in China: an analysis based on the global epidemiological data released in 2024', 'Physical activity and cancer risk: a dose‐response analysis for the Global Burden of Disease Study 2019', and 'Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer'.
Neoadjuvant Osimertinib for Resectable <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer
Cancer situation in China: an analysis based on the global epidemiological data released in 2024
Physical activity and cancer risk: a dose‐response analysis for the Global Burden of Disease Study 2019
Expert consensus on indocyanine green fluorescence imaging for thoracoscopic lung resection (The Version 2022)
International expert consensus on immunotherapy for early-stage non-small cell lung cancer
DNA methylation patterns at and beyond the histological margin of early-stage invasive lung adenocarcinoma radiologically manifested as pure ground-glass opacity
Different exposure duration of adjuvant icotinib in stage II-IIIA non-small cell lung cancer patients with positive EGFR mutation (ICOMPARE study): A randomized, open-label phase 2 study.
366 A randomized double-blind placebo-controlled phase III study evaluating perioperative toripalimab combined with platinum-based doublet chemotherapy in resectable stage III NSCLC
Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)
The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer
[Clinical pathway of primary lung cancer suegery (2013 edition)].